NCCN launches a roadmap for improving thyroid cancer care in low- and middle-income countries on the global stage

The NCCN Framework™ exists for many types of cancer—covering more than 80 percent of cancer diagnoses—as well as supportive care topics such as pain management, palliative care, and breast cancer prevention and detection. The NCCN Framework™ for thyroid cancer is the first new cancer to be added to this library in recent years. More than 500,000 people are diagnosed with thyroid cancer worldwide each year.¹ The NCCN Framework™ on Thyroid Cancer provides guidance on optimal treatment approaches for well-differentiated thyroid cancers in resource-constrained settings.

“The NCCN framework lays a realistic foundation for care tailored to different resource levels. It also shows which future investments can be most effective,” he said. Robert W CarlsonMD, CEO, NCCN. These tools represent NCCN’s longstanding commitment to improving equity and outcomes for people with cancer, no matter where they live. More than 800,000 registered users are out United State Rely on NCCN guidelines to provide the latest expert consensus-based cancer treatment recommendations. We want to make sure we provide accessible advice that improves outcomes for everyone.”

“Modern NCCN guidelines are widely used and respected around the world – but complete recommendations are not always possible in low-resource settings,” he said. World Thyroid Congress President Gregory W RandolphMD, FACS, FACE, FEBS (Endocrinology), MAMSE, Professor of Otolaryngology, Head and Neck Surgery, Claire and John Bertucci Chair of Thyroid Tumor Surgery, Harvard Medical School. “The World Congress on Thyroid Cancer brings together hundreds of providers from around the world. This year, rather than simply talking about the impracticality of guidelines intended for high-resource settings, we are presenting a solution… NCCN’s new framework for thyroid cancer. We feel that this Represents a global solution to thyroid cancer guidelines. The World Thyroid Cancer Congress has built a relationship that has been very satisfying and positive and we are committed to continuing to work with NCCN moving forward.”

The NCCN™ Framework applies the gold-standard recommendations from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) to 3 different levels of resources (basic, basic and enhanced). Recommendations at each level are color-coded so that resource stratified recommendations can be viewed in the context of the NCCN guidelines^®. NCCN Framework™ resources are identified as follows:

• Basic resourcesEssential services needed to provide a basic minimum standard of care.
• Basic resourcesIncludes services provided under the core resource framework as well as additional services that provide significant improvements in disease outcomes (eg survival) that are not prohibitively expensive.
• Enhanced resourcesServices provided under the core resource framework and additional services that provide lesser improvements in disease outcome and/or services that provide significant improvements in disease outcome but are more expensive in lower resource settings.

Robert HaddadMD, division chief, Head and Neck Oncology Center at Dana-Farber Cancer Institute Boston and professor of medicine, Harvard Medical School, is the chair of the multidisciplinary expert panel from all NCCN member institutions responsible for updating and maintaining the NCCN’s guidelines for thyroid cancer. He also played a leading role in creating the NCCN Framework™ for Thyroid Cancer and will join Dr. Koh at the Global Conference to present this new resource.

“We analyze all available evidence and review it with our colleagues and fellow team members at least once a year, and sometimes more often, to ensure that NCCN guidelines reflect the latest research and best practice,” said Dr. Haddad. “In the process of developing this NCCN framework, we have worked with the World Congress on Thyroid Cancer to solicit feedback from around the world. We really appreciate everyone’s efforts to help us establish criteria for designing recommendations that are optimally segmented into resources for maximum benefit to all people living with cancer. The global thyroid gland.

NCCN currently has more than 250 translations of clinical resources across 69 languages ​​as well as NCCN International Adaptations and NCCN Harmonized Guidelines™ (which are similar to the NCCN Framework™ but created for specific regions in joint efforts with local experts). View these free resources and learn more about NCCN’s collaborative work to define and promote high-quality, high-value, patient-centered cancer care globally at NCCN.org/global.

About the National Comprehensive Cancer Network
National Comprehensive Cancer Network^® (NCCN^®) is a non-profit alliance of leading cancer centers Dedicated to patient care, research and education. NCCN is dedicated to improving and facilitating high-quality, effective, equitable, and accessible cancer care so that all patients can live their best lives. Clinical Practice Guidelines for NCCN in Oncology (NCCN Guidelines^®provide transparent, evidence-based and expert-aligned recommendations for cancer treatment, prevention and support services; It is the recognized standard for clinical guidance and policy in the management of cancer and the most comprehensive and frequently updated clinical practice guideline available in any field of medicine. NCCN guidelines for patients^® Providing expert cancer treatment information to inform and empower patients and carers, through support from NCCN Foundation^®. NCCN also advances continuing education, global initiatives, policy, research collaboration, and publication in oncology. Visit NCCN.org for more information.

¹ https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00035-3/fulltext#back-bib1

Media contact:
Rachel Darwin
267-622-6624
[email protected]

Source: National Comprehensive Cancer Network